No Data
No Data
No Data
No Data
No Data
Piper Sandler Sticks to Its Buy Rating for Akebia Therapeutics (AKBA)
TipRanksApr 26 07:50 ET
Averoa Seeks EU Approval for Chronic Kidney Disease Drug
France-based Averoa filed a marketing authorization application to the European Medicines Agency for its AVA1014 drug to treat complications associated with chronic kidney disease. The biopharmaceutic
MT NewswiresApr 23 07:36 ET
Express News | Akebia Therapeutics Inc: on April 15, Company and Sta Entered Into Amendment #2 to Supply Agreement
Moomoo 24/7Apr 16 07:35 ET
Express News | Akebia Therapeutics Inc - Amendment Amends the Volume-Based Pricing Structure Under the Supply Agreement
Moomoo 24/7Apr 16 07:35 ET
Express News | Akebia Therapeutics Inc - Term of Supply Agreement Is Extended for an Additional Five Years and Expires on April 2, 2029
Moomoo 24/7Apr 16 07:35 ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersIN8bio (NASDAQ:INAB) stock increased by 47.7% to $1.61 during Wednesday's pre-market session. The market value of their outstanding shares is at $69.6 million. Jaguar Health (NASDAQ:JAGX) share
BenzingaApr 10 08:09 ET
No Data
No Data
amiable Llama_6295 : Hcw target price is $6
TrytosaveabitOP amiable Llama_6295: Yeah! I thank you for sharing! GL and big profits to ya!
amiable Llama_6295 TrytosaveabitOP:
amiable Llama_6295 : sold some to buy meli one of my
TrytosaveabitOP amiable Llama_6295: Very nice! But that’s a bit high for me to day trade it! Hehehe! But I hope you do great in MELI
View more comments...